4584.T Stock - Kidswell Bio Corporation
Unlock GoAI Insights for 4584.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $5.08B | $2.43B | $2.78B | $1.57B | $996.54M |
| Gross Profit | $1.64B | $1.04B | $1.53B | $1.02B | $876.97M |
| Gross Margin | 32.3% | 42.8% | 55.0% | 64.9% | 88.0% |
| Operating Income | $27.88M | $-1,335,597,000 | $-550,929,000 | $-651,139,000 | $-969,687,000 |
| Net Income | $-21,140,000 | $-1,422,078,000 | $-657,434,000 | $-550,863,000 | $-1,001,461,000 |
| Net Margin | -0.4% | -58.5% | -23.7% | -35.1% | -100.5% |
| EPS | $-0.52 | $-40.23 | $-20.77 | $-17.86 | $-34.79 |
Kidswell Bio Corporation develops pharmaceuticals for the treatment of rare and intractable diseases in Japan. Its pipeline products include GND-004 for the treatment of ophthalmic disease and oncology; GND-007 for the treatment of immunological disease; and antibodies for oncology. The company pipeline products also include GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for ophthalmic disease; GBS-008 for infectious diseases; and GBS-011 for renal disease. In addition, its products also include GCT-101 for alveolar cleft; GCT-102 for congenital isolated hypoganglionosis; and other pipeline products for ophthalmologic diseases, cerebral palsy, peripheral nerve palsy, fracture, and spinal cord injury. The company was formerly known as Gene Techno Science Co.,Ltd. and changed its name to Kidswell Bio Corporation in July 2021. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
4584.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | — | $-1.95 | — | — |
Q3 2025 | Aug 13, 2025 | — | $3.75 | — | — |
Q2 2025 | May 13, 2025 | — | $3.98 | — | — |
Q1 2025 | Feb 12, 2025 | — | $1.33 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-1.62 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-4.49 | — | — |
Q2 2024 | May 14, 2024 | — | $-17.51 | — | — |
Q1 2024 | Feb 7, 2024 | — | $0.88 | — | — |
Q4 2023 | Nov 8, 2023 | — | $-9.29 | — | — |
Q3 2023 | Aug 7, 2023 | — | $-14.68 | — | — |
Q2 2023 | May 12, 2023 | — | $-14.43 | — | — |
Q1 2023 | Feb 7, 2023 | — | $-4.81 | — | — |
Q4 2022 | Nov 8, 2022 | — | $1.22 | — | — |
Q3 2022 | Aug 5, 2022 | — | — | — | — |
Q2 2022 | May 12, 2022 | — | $-14.03 | — | — |
Q1 2022 | Feb 4, 2022 | — | $11.73 | — | — |
Q4 2021 | Nov 5, 2021 | — | $-4.87 | — | — |
Q3 2021 | Aug 12, 2021 | — | $-10.50 | — | — |
Q2 2021 | May 13, 2021 | — | $-11.30 | — | — |
Q1 2021 | Feb 5, 2021 | — | $1.06 | — | — |
Latest News
Frequently Asked Questions about 4584.T
What is 4584.T's current stock price?
What is the analyst price target for 4584.T?
What sector is Kidswell Bio Corporation in?
What is 4584.T's market cap?
Does 4584.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 4584.T for comparison